OnKure Therapeutics Announces Registration Of Up To $100M At-The-Market Offering Of Class A Common Stock Through Leerink Partners
https://www.sec.gov/Archives/edgar/data/1637715/000119312526332839/okur_424b5-20260804.htm
OnKure is planning to sell new shares of its company stock (up to $100 million worth) to raise money. This means the company needs cash, so watch to see what they'll use it for—like medicine research or operations—which tells you if management thinks the business is headed in a good direction.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.